AB SCIEX Launches Innovative Solutions For Therapeutics Development And Analysis
6/16/2014 11:43:46 AM
FRAMINGHAM, Mass.--(BUSINESS WIRE)--AB SCIEX, a global leader in life science analytical technologies, today introduced its latest additions to a growing line of solutions for the characterization of biotherapeutics such as monoclonal antibodies and emerging protein classes at both the intact protein and peptide levels. These solutions – TripleTOF 6600 system with SWATH and BioPharmaView – are ideal for studying changes in biotherapeutics and help researchers gain rapid, accurate, and confident understanding of compounds in this area of drug development.
Help employers find you! Check out all the jobs and post your resume.
comments powered by